{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T23:02:00Z","timestamp":1791932520327,"version":"4.3.4"},"reference-count":84,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Perinatology"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.clp.2014.08.011","type":"journal-article","created":{"date-parts":[[2014,9,23]],"date-time":"2014-09-23T15:45:16Z","timestamp":1411487116000},"page":"925-943","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"title":["Vascular Endothelial Growth Factor Antagonist Therapy for Retinopathy of Prematurity"],"prefix":"10.1016","volume":"41","author":[{"given":"M. Elizabeth","family":"Hartnett","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clp.2014.08.011_bib1","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1093\/hmg\/ddl238","article-title":"VEGF polymorphisms are associated with neovascular age-related macular degeneration","volume":"15","author":"Churchill","year":"2006","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.clp.2014.08.011_bib2","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1172\/JCI42437","article-title":"Therapeutic targets in age-related macular disease","volume":"120","author":"Bird","year":"2010","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.clp.2014.08.011_bib3","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1016\/j.ajpath.2013.12.023","article-title":"VEGFA activates erythropoietin receptor and enhances VEGFR2-mediated pathological angiogenesis","volume":"184","author":"Yang","year":"2014","journal-title":"Am J Pathol"},{"key":"10.1016\/j.clp.2014.08.011_bib4","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1056\/NEJM199412013312203","article-title":"Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders","volume":"331","author":"Aiello","year":"1994","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clp.2014.08.011_bib5","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1007\/s00417-010-1315-z","article-title":"A\u00a0review of clinical trials of anti-VEGF agents for diabetic retinopathy","volume":"248","author":"Nicholson","year":"2010","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.clp.2014.08.011_bib6","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1167\/iovs.03-1303","article-title":"Genetic polymorphisms and retinopathy of prematurity","volume":"45","author":"Cooke","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.clp.2014.08.011_bib7","doi-asserted-by":"crossref","first-page":"332","DOI":"10.3928\/01913913-20120821-03","article-title":"An evidence-based meta-analysis of vascular endothelial growth factor inhibition in pediatric retinal diseases: part 1. Retinopathy of prematurity","volume":"49","author":"Mititelu","year":"2012","journal-title":"J\u00a0Pediatr Ophthalmol Strabismus"},{"key":"10.1016\/j.clp.2014.08.011_bib8","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1056\/NEJMoa1007374","article-title":"Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity","volume":"364","author":"Mintz-Hittner","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clp.2014.08.011_bib9","doi-asserted-by":"crossref","first-page":"18751","DOI":"10.1073\/pnas.0905010106","article-title":"An essential role for RPE-derived soluble VEGF in the maintenance of the choriocapillaris","volume":"106","author":"Saint-Geniez","year":"2009","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"10.1016\/j.clp.2014.08.011_bib10","doi-asserted-by":"crossref","first-page":"e3554","DOI":"10.1371\/journal.pone.0003554","article-title":"Endogenous VEGF is required for visual function: evidence for a survival role on muller cells and photoreceptors","volume":"3","author":"Saint-Geniez","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.clp.2014.08.011_bib11","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1016\/j.ophtha.2013.03.046","article-title":"Seven-year outcomes in ranibizumab-treated patients in ANCHOR, MARINA, and HORIZON: a Multicenter Cohort Study (SEVEN-UP)","volume":"120","author":"Rofagha","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clp.2014.08.011_bib12","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2353\/ajpath.2007.061237","article-title":"Vascular endothelial growth factor-A is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injury","volume":"171","author":"Nishijima","year":"2007","journal-title":"Am J Pathol"},{"key":"10.1016\/j.clp.2014.08.011_bib13","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.ajo.2011.07.005","article-title":"Serum concentrations of bevacizumab (Avastin) and vascular endothelial growth factor in infants with retinopathy of prematurity","volume":"153","author":"Sato","year":"2012","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.clp.2014.08.011_bib14","doi-asserted-by":"crossref","first-page":"e74","DOI":"10.1111\/j.1755-3768.2012.02469.x","article-title":"Serum concentrations of vascular endothelial growth factor in an infant treated with ranibizumab for retinopathy of prematurity","volume":"91","author":"Hoerster","year":"2013","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.clp.2014.08.011_bib15","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1001\/archophthalmol.2012.592","article-title":"Reactivation of retinopathy of prematurity after bevacizumab injection","volume":"130","author":"Hu","year":"2012","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.clp.2014.08.011_bib16","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/archophthalmol.2011.1802","article-title":"Significant treatment failure with intravitreous bevacizumab for retinopathy of prematurity","volume":"130","author":"Patel","year":"2012","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.clp.2014.08.011_bib17","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.earlhumdev.2007.11.009","article-title":"Retinopathy of prematurity: a global perspective of the epidemics, population of babies at risk and implications for control","volume":"84","author":"Gilbert","year":"2008","journal-title":"Early Hum Dev"},{"key":"10.1016\/j.clp.2014.08.011_bib18","first-page":"501","article-title":"An update on progress and the changing epidemiology of causes of childhood blindness worldwide","volume":"16","author":"Kong","year":"2012","journal-title":"J\u00a0AAPOS"},{"key":"10.1016\/j.clp.2014.08.011_bib19","first-page":"344","article-title":"Retinopathy of prematurity care: patterns of care and workforce analysis","volume":"12","author":"Kemper","year":"2008","journal-title":"J\u00a0AAPOS"},{"key":"10.1016\/j.clp.2014.08.011_bib20","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1542\/peds.2006-1088","article-title":"Genetic susceptibility to retinopathy of prematurity","volume":"118","author":"Bizzarro","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.clp.2014.08.011_bib21","first-page":"1133","article-title":"Studies on retinal neovascularization. Friedenwald Lecture","volume":"19","author":"Patz","year":"1980","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.clp.2014.08.011_bib22","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1136\/bjo.38.7.433","article-title":"Direct observation of the effect of oxygen on developing vessels: preliminary report","volume":"38","author":"Ashton","year":"1954","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.clp.2014.08.011_bib23","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1136\/bjo.68.10.689","article-title":"Editorial: retrolental fibroplasia now retinopathy of prematurity","volume":"68","author":"Ashton","year":"1984","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.clp.2014.08.011_bib24","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/359843a0","article-title":"Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis","volume":"359","author":"Shweiki","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.clp.2014.08.011_bib25","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1542\/peds.105.2.295","article-title":"Supplemental therapeutic oxygen for prethreshold retinopathy of prematurity (STOP-ROP), a randomized, controlled trial. I: primary outcomes","volume":"105","author":"Group TS-RMS","year":"2000","journal-title":"Pediatrics"},{"key":"10.1016\/j.clp.2014.08.011_bib26","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1097\/01.iae.0000244292.86627.1e","article-title":"Rethinking stop-ROP: is it worthwhile trying to modulate excessive VEGF levels in prethreshold ROP eyes by systemic intervention? A review of the role of oxygen, light adaptation state, and anemia in prethreshold ROP","volume":"26","author":"Gaynon","year":"2006","journal-title":"Retina"},{"key":"10.1016\/j.clp.2014.08.011_bib27","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1056\/NEJMoa0911783","article-title":"Early CPAP versus surfactant in extremely preterm infants","volume":"362","author":"SUPPORT Study Group of the Eunice Kennedy Shriver NICHD Neonatal Research Network","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clp.2014.08.011_bib28","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1056\/NEJMoa1302298","article-title":"Oxygen saturation and outcomes in preterm infants","volume":"368","author":"Stenson","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clp.2014.08.011_bib29","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1001\/jama.2013.5555","article-title":"Effects of targeting higher vs lower arterial oxygen saturations on death or disability in extremely preterm infants: a randomized clinical trial","volume":"309","author":"Schmidt","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.clp.2014.08.011_bib30","first-page":"229","article-title":"Effects of oxygen on the development and severity of retinopathy of prematurity","volume":"17","author":"Hartnett","year":"2013","journal-title":"J\u00a0AAPOS"},{"key":"10.1016\/j.clp.2014.08.011_bib31","first-page":"94","article-title":"Current concepts of oxygen management and ROP","volume":"9","author":"Owen","year":"2014","journal-title":"J\u00a0Ophthalmic Vis Res"},{"key":"10.1016\/j.clp.2014.08.011_bib32","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/sj.jp.7211040","article-title":"Arterial oxygen fluctuation and retinopathy of prematurity in very-low-birth-weight infants","volume":"24","author":"York","year":"2004","journal-title":"J\u00a0Perinatol"},{"key":"10.1016\/j.clp.2014.08.011_bib33","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1159\/000308454","article-title":"Blood gases and retinopathy of prematurity: the ELGAN Study","volume":"99","author":"Hauspurg","year":"2011","journal-title":"Neonatology"},{"key":"10.1016\/j.clp.2014.08.011_bib34","first-page":"840","article-title":"Inhibition of NAD(P)H oxidase reduces apoptosis and avascular retina in an animal model of retinopathy of prematurity","volume":"13","author":"Saito","year":"2007","journal-title":"Mol Vis"},{"key":"10.1016\/j.clp.2014.08.011_bib35","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1001\/archophthalmol.2010.158","article-title":"Association of retinal vascular endothelial growth factor with avascular retina in a rat model of retinopathy of prematurity","volume":"128","author":"Budd","year":"2010","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.clp.2014.08.011_bib36","doi-asserted-by":"crossref","first-page":"e638","DOI":"10.1542\/peds.2008-2697","article-title":"Early weight gain predicts retinopathy in preterm infants: new, simple, efficient approach to screening","volume":"123","author":"Hellstrom","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.clp.2014.08.011_bib37","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/BF02482607","article-title":"Oxygen-induced retinopathy in the rat: possible contribution of peroxidation reactions","volume":"74","author":"Penn","year":"1990","journal-title":"Doc Ophthalmol"},{"key":"10.1016\/j.clp.2014.08.011_bib38","first-page":"209","article-title":"Vitamin E and retinopathy of prematurity: the clinical investigator's perspective on antioxidant therapy: side effects and balancing risks and benefits","volume":"24","author":"Phelps","year":"1988","journal-title":"Birth Defects Orig Artic Ser"},{"key":"10.1016\/j.clp.2014.08.011_bib39","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/S0022-3476(97)70031-3","article-title":"Vitamin E prophylaxis to reduce retinopathy of prematurity: a reappraisal of published trials","volume":"131","author":"Raju","year":"1997","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.clp.2014.08.011_bib40","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1001\/archopht.121.12.1684","article-title":"Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial","volume":"121","author":"Early Treatment for Retinopathy of Prematurity Cooperative Group","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.clp.2014.08.011_bib41","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1001\/archopht.1996.01100130413008","article-title":"Multicenter trial of cryotherapy for retinopathy of prematurity. Snellen visual acuity and structural outcome at 51\/2 years after randomization","volume":"114","author":"Cryotherapy for Retinopathy of Prematurity Cooperative Group","year":"1996","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.clp.2014.08.011_bib42","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/00006982-200306000-00006","article-title":"Features associated with surgical outcome in patients with stages 4 and 5 retinopathy of prematurity","volume":"23","author":"Hartnett","year":"2003","journal-title":"Retina"},{"key":"10.1016\/j.clp.2014.08.011_bib43","first-page":"177","article-title":"Training fellows for retinopathy of prematurity care: a web-based survey","volume":"16","author":"Wong","year":"2012","journal-title":"J\u00a0AAPOS"},{"key":"10.1016\/j.clp.2014.08.011_bib44","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1016\/S0161-6420(03)00831-5","article-title":"Telemedicine approach to screening for severe retinopathy of prematurity: a pilot study","volume":"110","author":"Ells","year":"2003","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clp.2014.08.011_bib45","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1542\/peds.2012-2996","article-title":"Screening examination of premature infants for retinopathy of prematurity","volume":"131","author":"Fierson","year":"2013","journal-title":"Pediatrics"},{"key":"10.1016\/j.clp.2014.08.011_bib46","first-page":"281","article-title":"Retinopathy of prematurity: involution, factors predisposing to retinal detachment, and expected utility of preemptive surgical reintervention","volume":"103","author":"Coats","year":"2005","journal-title":"Trans Am Ophthalmol Soc"},{"key":"10.1016\/j.clp.2014.08.011_bib47","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/00006982-200404000-00008","article-title":"Retinal features predictive of progressive stage 4 retinopathy of prematurity","volume":"24","author":"Hartnett","year":"2004","journal-title":"Retina"},{"key":"10.1016\/j.clp.2014.08.011_bib48","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1136\/bjo.38.7.397","article-title":"Effect of oxygen on developing retinal vessels with particular reference to the problem of retrolental fibroplasia","volume":"38","author":"Ashton","year":"1954","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.clp.2014.08.011_bib49","first-page":"101","article-title":"Oxygen-induced retinopathy in the mouse","volume":"35","author":"Smith","year":"1994","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.clp.2014.08.011_bib50","doi-asserted-by":"crossref","first-page":"F371","DOI":"10.1136\/fetalneonatal-2011-301121","article-title":"Aggressive posterior retinopathy of prematurity in large preterm babies in South India","volume":"97","author":"Shah","year":"2012","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"10.1016\/j.clp.2014.08.011_bib51","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0002-9394(54)90845-4","article-title":"Oxygen studies in retrolental fibroplasia","volume":"38","author":"Patz","year":"1954","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.clp.2014.08.011_bib52","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1056\/NEJMra1208129","article-title":"Mechanisms and management of retinopathy of prematurity","volume":"367","author":"Hartnett","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clp.2014.08.011_bib53","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1203\/00006450-199412000-00007","article-title":"Exposure to alternating hypoxia and hyperoxia causes severe proliferative retinopathy in the newborn rat","volume":"36","author":"Penn","year":"1994","journal-title":"Pediatr Res"},{"key":"10.1016\/j.clp.2014.08.011_bib54","first-page":"1925","article-title":"Significant reduction of the panretinal oxygenation response after 28% supplemental oxygen recovery in experimental ROP","volume":"41","author":"Berkowitz","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.clp.2014.08.011_bib55","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1016\/S0140-6736(95)92475-2","article-title":"Transcutaneous oxygen levels in retinopathy of prematurity","volume":"346","author":"Cunningham","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.clp.2014.08.011_bib56","doi-asserted-by":"crossref","first-page":"403","DOI":"10.3109\/02713689608995831","article-title":"The effect of postnatal growth retardation on abnormal neovascularization in the oxygen exposed neonatal rat","volume":"15","author":"Holmes","year":"1996","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.clp.2014.08.011_bib57","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.ajpath.2013.05.011","article-title":"Short hairpin RNA-mediated knockdown of VEGFA in muller cells reduces intravitreal neovascularization in a rat model of retinopathy of prematurity","volume":"183","author":"Wang","year":"2013","journal-title":"Am J Pathol"},{"key":"10.1016\/j.clp.2014.08.011_bib58","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1167\/iovs.13-13755","article-title":"Targeting M\u00fcller cell-derived VEGF164 to reduce intravitreal neovascularization in the rat model of retinopathy of prematurity","volume":"55","author":"Jiang","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.clp.2014.08.011_bib59","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.earlhumdev.2012.09.019","article-title":"Treatment of retinopathy of prematurity with vascular endothelial growth factor inhibitors","volume":"88","author":"Mintz-Hittner","year":"2012","journal-title":"Early Hum Dev"},{"key":"10.1016\/j.clp.2014.08.011_bib60","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1001\/archophthalmol.2012.592","article-title":"Reactivation of retinopathy of prematurity after bevacizumab injection","volume":"130","author":"Hu","year":"2012","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.clp.2014.08.011_bib61","doi-asserted-by":"crossref","first-page":"5177","DOI":"10.1167\/iovs.08-2584","article-title":"Through the eyes of a child: understanding retinopathy through ROP the Friedenwald lecture","volume":"49","author":"Smith","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.clp.2014.08.011_bib62","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1001\/archopht.123.7.991","article-title":"The international classification of retinopathy of prematurity revisited","volume":"123","author":"An International Committee for the Classification of Retinopathy of Prematurity","year":"2005","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.clp.2014.08.011_bib63","series-title":"The New Visual Neurosciences","first-page":"1483","article-title":"Retinopathy of prematurity: a template for studying retinal vascular disease","author":"Hartnett","year":"2014"},{"key":"10.1016\/j.clp.2014.08.011_bib64","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1167\/iovs.08-3256","article-title":"The role of supplemental oxygen and JAK\/STAT signaling in intravitreous neovascularization in a ROP rat model","volume":"50","author":"Byfield","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.clp.2014.08.011_bib65","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1167\/iovs.07-1356","article-title":"Activated NAD(P)H oxidase from supplemental oxygen induces neovascularization independent of VEGF in retinopathy of prematurity model","volume":"49","author":"Saito","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.clp.2014.08.011_bib66","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1016\/S0024-3205(99)00526-3","article-title":"Effects of intraocular or systemic administration of neutralizing antibody against vascular endothelial growth factor on the murine experimental model of retinopathy","volume":"65","author":"Sone","year":"1999","journal-title":"Life Sci"},{"key":"10.1016\/j.clp.2014.08.011_bib67","first-page":"345","article-title":"Neutralizing antibody to VEGF reduces intravitreous neovascularization and does not interfere with vascularization of avascular retina in an ROP model","volume":"14","author":"Geisen","year":"2008","journal-title":"Mol Vis"},{"key":"10.1016\/j.clp.2014.08.011_bib68","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.exer.2009.06.011","article-title":"Reduction in endothelial tip cell filopodia corresponds to reduced intravitreous but not intraretinal vascularization in a model of ROP","volume":"89","author":"Budd","year":"2009","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.clp.2014.08.011_bib69","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1182\/blood-2006-07-037952","article-title":"Orientation of endothelial cell division is regulated by VEGF signaling during blood vessel formation","volume":"109","author":"Zeng","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.clp.2014.08.011_bib70","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.1167\/iovs.08-1780","article-title":"Neutralizing VEGF decreases tortuosity and alters endothelial cell division orientation in arterioles and veins in a rat model of ROP: relevance to plus disease","volume":"49","author":"Hartnett","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.clp.2014.08.011_bib71","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1167\/iovs.13-13429","article-title":"Quantitative analyses of retinal vascular area and density after different methods to reduce VEGF in a rat model of retinopathy of prematurity","volume":"55","author":"Wang","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.clp.2014.08.011_bib72","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1167\/iovs.07-0632","article-title":"Vascular precursors in developing human retina","volume":"49","author":"Hasegawa","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.clp.2014.08.011_bib73","first-page":"1201","article-title":"The effect of oxygen on vasoformative cell division: evidence that \u2018physiological hypoxia\u2019 is the stimulus for normal retinal vasculogenesis","volume":"36","author":"Chan-Ling","year":"1995","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.clp.2014.08.011_bib74","doi-asserted-by":"crossref","first-page":"F327","DOI":"10.1136\/archdischild-2012-302365","article-title":"Serious adverse events and visual outcomes of rescue therapy using adjunct bevacizumab to laser and surgery for retinopathy of prematurity. The Indian Twin Cities Retinopathy of Prematurity Screening database Report number 5","volume":"98","author":"Jalali","year":"2013","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"10.1016\/j.clp.2014.08.011_bib75","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1001\/archopht.120.11.1470","article-title":"Evidence-based screening criteria for retinopathy of prematurity: natural history data from the CRYO-ROP and LIGHT-ROP studies","volume":"120","author":"Reynolds","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.clp.2014.08.011_bib76","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1167\/iovs.13-11625","article-title":"Anti-VEGF antibody leads to later atypical intravitreous neovascularization and activation of angiogenic pathways in a rat model of retinopathy of prematurity","volume":"54","author":"McCloskey","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.clp.2014.08.011_bib77","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1056\/NEJMoa1102673","article-title":"Ranibizumab and bevacizumab for neovascular age-related macular degeneration","volume":"364","author":"Martin","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clp.2014.08.011_bib78","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1136\/bjophthalmol-2012-302451","article-title":"Plasma levels of vascular endothelial growth factor before and after intravitreal injection of bevacizumab, ranibizumab and pegaptanib in patients with age-related macular degeneration, and in patients with diabetic macular oedema","volume":"97","author":"Zehetner","year":"2013","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.clp.2014.08.011_bib79","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1152\/jappl.1995.78.6.2039","article-title":"Peroxide-cyclooxygenase interactions in postasphyxial changes in retinal and choroidal hemodynamics","volume":"78","author":"Chemtob","year":"1995","journal-title":"J\u00a0Appl Physiol (1985)"},{"key":"10.1016\/j.clp.2014.08.011_bib80","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1167\/iovs.05-1473","article-title":"The Dipeptide Arg-Gln inhibits retinal neovascularization in the mouse model of oxygen-induced retinopathy","volume":"47","author":"Neu","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.clp.2014.08.011_bib81","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/nm1591","article-title":"Increased dietary intake of omega-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis","volume":"13","author":"Connor","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.clp.2014.08.011_bib82","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/S0140-6736(13)60178-6","article-title":"Retinopathy of prematurity","volume":"382","author":"Hellstr\u00f6m","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.clp.2014.08.011_bib83","first-page":"143","article-title":"Association between higher cumulative doses of recombinant erythropoietin and risk for retinopathy of prematurity","volume":"10","author":"Brown","year":"2006","journal-title":"J\u00a0AAPOS"},{"key":"10.1016\/j.clp.2014.08.011_bib84","doi-asserted-by":"crossref","first-page":"e119","DOI":"10.1542\/peds.2013-0143","article-title":"A\u00a0randomized, masked, placebo-controlled study of darbepoetin alfa in preterm infants","volume":"132","author":"Ohls","year":"2013","journal-title":"Pediatrics"}],"container-title":["Clinics in Perinatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0095510814000876?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0095510814000876?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T15:56:00Z","timestamp":1758815760000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0095510814000876"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":84,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S0095510814000876"],"URL":"https:\/\/doi.org\/10.1016\/j.clp.2014.08.011","relation":{},"ISSN":["0095-5108"],"issn-type":[{"value":"0095-5108","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vascular Endothelial Growth Factor Antagonist Therapy for Retinopathy of Prematurity","name":"articletitle","label":"Article Title"},{"value":"Clinics in Perinatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clp.2014.08.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}